Mechanism of oligonucleotide release from cationic liposomes. O Zelphati, FC Szoka Jr Proceedings of the National Academy of Sciences 93 (21), 11493-11498, 1996 | 837 | 1996 |
Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers TB Wyman, F Nicol, O Zelphati, PV Scaria, C Plank, FC Szoka Biochemistry 36 (10), 3008-3017, 1997 | 672 | 1997 |
Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells O Zelphati, LS Uyechi, LG Barron, FC Szoka Jr Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 1390 (2 …, 1998 | 416 | 1998 |
Magnetically enhanced nucleic acid delivery. Ten years of magnetofection—Progress and prospects C Plank, O Zelphati, O Mykhaylyk Advanced drug delivery reviews 63 (14-15), 1300-1331, 2011 | 392 | 2011 |
Intracellular delivery of proteins with a new lipid-mediated delivery system O Zelphati, Y Wang, S Kitada, JC Reed, PL Felgner, J Corbeil Journal of Biological Chemistry 276 (37), 35103-35110, 2001 | 325 | 2001 |
Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids O Zelphati, FC Szoka Pharmaceutical research 13, 1367-1372, 1996 | 321 | 1996 |
Stable and monodisperse lipoplex formulations for gene delivery O Zelphati, C Nguyen, M Ferrari, J Felgner, Y Tsai, PL Felgner Gene therapy 5 (9), 1272-1282, 1998 | 196 | 1998 |
Gene chemistry: functionally and conformationally intact fluorescent plasmid DNA O Zelphati, X Liang, P Hobart, PL Felgner Human gene therapy 10 (1), 15-24, 1999 | 161 | 1999 |
Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet? O Zelphati, FC Szoka Jr Journal of controlled release 41 (1-2), 99-119, 1996 | 138 | 1996 |
Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms O Zelphati, JL Imbach, N Signoret, G Zon, B Rayner, L Leserman Nucleic acids research 22 (20), 4307-4314, 1994 | 122 | 1994 |
Analytical methods for the characterization of cationic lipid–nucleic acid complexes ME Ferrari, CM Nguyen, O Zelphati, Y Tsai, PL Felgner Human gene therapy 9 (3), 341-351, 1998 | 105 | 1998 |
Recent advances in magnetofection and its potential to deliver siRNAs in vitro O Mykhaylyk, O Zelphati, E Hammerschmid, M Anton, J Rosenecker, ... siRNA and miRNA Gene Silencing: From Bench to Bedside, 1-36, 2009 | 93 | 2009 |
siRNA delivery by magnetofection. O Mykhaylyk, O Zelphati, J Rosenecker, C Plank Current opinion in molecular therapeutics 10 (5), 493-505, 2008 | 91 | 2008 |
Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes O Zelphati, G ZON, LEE LESERMAN Antisense research and development 3 (4), 323-338, 1993 | 89 | 1993 |
PNA-dependent gene chemistry: stable coupling of peptides and oligonucleotides to plasmid DNA O Zelphati, X Liang, C Nguyen, S Barlow, S Sheng, Z Shao, PL Felgner Biotechniques 28 (2), 304-316, 2000 | 87 | 2000 |
How are nucleic acids released in cells from cationic lipid-nucleic acid complexes? FC Szoka, Y Xu, O Zelphati Journal of Liposome Research 6 (3), 567-587, 1996 | 59 | 1996 |
High transfection efficiency of neural stem cells with magnetofection C Sapet, N Laurent, A de Chevigny, LL Gourrierec, E Bertosio, O Zelphati, ... Biotechniques 50 (3), 187-189, 2011 | 53 | 2011 |
Liposomal magnetofection O Mykhaylyk, Y Sánchez-Antequera, D Vlaskou, E Hammerschmid, ... Liposomes: Methods and Protocols, Volume 1: Pharmaceutical Nanocarriers, 487-525, 2010 | 50 | 2010 |
Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes O Zelphati, E Wagner, L Leserman Antiviral research 25 (1), 13-25, 1994 | 49 | 1994 |
Magnetic Nanoparticles Enhance Adenovirus Transduction In Vitro and In Vivo C Sapet, C Pellegrino, N Laurent, F Sicard, O Zelphati Pharmaceutical research 29, 1203-1218, 2012 | 47 | 2012 |